Läkemedelsverket: Beteendemässiga och psykiska symtom vid demenssjukdom – BPSD [In English: Drug therapy and treatment for Behavioral and Psychological Symptoms of dementia – BPSD. Information from the Medical Products Agency]. Retrieved June 10, 2012 from http://www.lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/BPSD_bakgrund_webb.pdf
Liperoti R, Pedone C, Corsonello A: Antipsychotics for the treatment of Behavioral and Psychological Symptoms of Dementia (BPSD). Current Neuropharmacology. 2008, 6: 117-124. 10.2174/157015908784533860.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cerejeira J, Lagarto L, Mukaetova-Ladinska EB: Behavioral and psychological symptoms of dementia. Frontiers in Neurology. 2012, 3: 73-
Article
CAS
PubMed
PubMed Central
Google Scholar
Lövheim H, Sandman PO, Kallin K, Karlsson S, Gustafson Y: Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. Int Psychogeriatr. 2006, 18: 713-26. 10.1017/S1041610206003930.
Article
PubMed
Google Scholar
Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. J Am Med Assoc. 2005, 293: 596-608. 10.1001/jama.293.5.596.
Article
CAS
Google Scholar
Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA, CATIE-AD Study Group: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Eng J Med. 2006, 355: 1525-1538. 10.1056/NEJMoa061240.
Article
CAS
Google Scholar
Neil W, Curran S, Wattis J: Antipsychotic prescribing in older people. Age Ageing. 2003, 32: 475-483. 10.1093/ageing/afg061.
Article
PubMed
Google Scholar
Gareri P, De Fazio P, Stilo MA, Ferreri G, De Sarro G: Conventional and atypical antipsychotics in the elderly: a review. Clin Drug Investig. 2003, 23: 287-322. 10.2165/00044011-200323050-00001.
Article
CAS
PubMed
Google Scholar
Gareri P, Cortoneo A, Marchisio U, Curcio M, De Sarro G: Risperidone in the treatment of behavioral disorders in elderly patients with dementia. Arch Gerontol Geriatr Suppl. 2001, 7: 173-82.
Article
CAS
PubMed
Google Scholar
Gareri P, De Fazio P, De Fazio S, Marigliano N, Ferreri Ibbadu G, De Sarro G: Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging. 2006, 23: 937-56. 10.2165/00002512-200623120-00002.
Article
CAS
PubMed
Google Scholar
Devanand DP, Sackeim HA, Brown RP, Mayeux R: A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. Arch Neurol. 1989, 46: 854-857. 10.1001/archneur.1989.00520440036018.
Article
CAS
PubMed
Google Scholar
Melkersson KI, Dahl ML, Hulting AL: Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism. Psychopharmacology. 2004, 175: 1-6.
Article
CAS
PubMed
Google Scholar
Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. J Am Med Assoc. 2005, 294: 1934-1943. 10.1001/jama.294.15.1934.
Article
CAS
Google Scholar
Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA: Antipsychotic drug use and mortality in older adults in dementia. Ann Intern Med. 2007, 146: 775-786.
Article
PubMed
Google Scholar
National Institute for Health and Clinical Excellence (NICE): Dementia - Supporting people with dementia and their careers in health and social care. Retrieved June 24, 2012 from: http://www.nice.org.uk/nicemedia/live/10998/30318/30318.pdf
Rochon PA, Normand SL, Gomes T, Gill SS, Anderson GM, Melo M, Sykora K, Lipscombe L, Bell CM, Gurwitz JH: Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008, 168: 1090-1096. 10.1001/archinte.168.10.1090.
Article
PubMed
Google Scholar
O’Connor DW, Griffith J, McSweeney K: Changes to psychotropic medications in the six month after admission to nursing homes in Melbourne, Australia. Int Psychogeriatr. 2010, 22: 1149-53. 10.1017/S1041610210000165.
Article
PubMed
Google Scholar
Selbæk G, Kirkevold Ø, Engedal K: The course of psychiatric and behavioural symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes a 12-month follow-up study. Am J Geriatr Psychiatry. 2008, 16: 528-536. 10.1097/JGP.0b013e318167ae76.
Article
PubMed
Google Scholar
Pellfolk TJ, Gustafson Y, Bucht G, Karlsson S: Effects of a restraint minimization program on staff knowledge, attitudes, and practice: a cluster randomized trial. J Am Geriatr Soc. 2010, 58: 62-9. 10.1111/j.1532-5415.2009.02629.x.
Article
PubMed
Google Scholar
Sandman PO, Adolfsson R, Norberg A, Nyström L, Winblad B: Long-term care of the elderly. A descriptive study of 3600 institutionalized patients in the county of Vasterbotten, Sweden. Compr Gerontol A. 1988, 2: 120-132.
CAS
PubMed
Google Scholar
Adolfsson R, Gottfries CG, Nyström L, Winblad B: Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand. 1981, 63: 225-244.
Article
CAS
PubMed
Google Scholar
Folstein MF, Folstein SE, McHugh PR: ”Mini-mental state”: a practical method for grading the cognitive state of patients for the clinican. J Psychiatr Res. 1975, 12: 189-198. 10.1016/0022-3956(75)90026-6.
Article
CAS
PubMed
Google Scholar
Lövheim H, Sandman PO, Karlsson S, Gustafson Y: Behavioral and psychological symptoms of dementia in relation to level of cognitive impairment. Int Psychogeriatr. 2008, 20: 777-89.
Article
PubMed
Google Scholar
Eriksson L, Pelling H: Psykoser [In English: Psychoses]. Läkemedelsboken. 2005/2006. 2005, Stockholm: Apoteket AB, 806-814.
Google Scholar
Cohen-Mansfield J, Lipson S, Werner P, Billig N, Taylor L, Woosley R: Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med. 1999, 159: 1733-1740. 10.1001/archinte.159.15.1733.
Article
CAS
PubMed
Google Scholar
Ruths S, Straand J, Nygaard HA, Aarsland D: Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study – The Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry. 2008, 23: 889-895. 10.1002/gps.1998.
Article
PubMed
Google Scholar
Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F: A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry. 2003, 64: 134-143. 10.4088/JCP.v64n0205.
Article
CAS
PubMed
Google Scholar
Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A, The HGEU Study Group: Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2000, 57: 968-76. 10.1001/archpsyc.57.10.968.
Article
CAS
PubMed
Google Scholar
Gareri P, Cotroneo A, Lacava R, Seminara G, Marigliano N, Loiacono A, De Sarro G: Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Arch Gerontol Geriatr Suppl. 2004, 9: 207-15.
Article
CAS
PubMed
Google Scholar
Lövheim H, Gustafson Y, Karlsson S, Sandman PO: Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old people in geriatric care in 2000 and 2007. Int Psychogeriatr. 2011, 23: 1616-22. 10.1017/S1041610211001712.
Article
PubMed
Google Scholar
Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R: Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. Br Med J. 2006, 332: 756-61. 10.1136/bmj.38782.575868.7C.
Article
Google Scholar
O’Connor DW, Ames D, Gardner B, King M: Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. Int Psychogeriatr. 2009, 21: 241-251. 10.1017/S1041610208008223.
Article
PubMed
Google Scholar
Maidment ID, Fox CG, Boustani M, Rodriguez J, Brown RC, Katona CL: Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis. Ann Pharmacother. 2008, 42: 32-38.
Article
PubMed
Google Scholar
Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C: Management of behavioral problems in Alzheimer’s disease. Int Psychogeriatr. 2010, 22: 346-72. 10.1017/S1041610209991505.
Article
PubMed
Google Scholar
Finkel SI: Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer’s disease. Clin Ther. 2004, 26: 980-990. 10.1016/S0149-2918(04)90172-5.
Article
CAS
PubMed
Google Scholar
Pollock BG, Mulsant BH, Rosen J, Sweet RA, Mazumdar S, Bharucha A, Marin R, Jacob NJ, Huber KA, Kastango KB, Chew ML: Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry. 2002, 159: 460-465. 10.1176/appi.ajp.159.3.460.
Article
PubMed
Google Scholar
Nyth AL, Gottfries CG: The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic Multicentre study. Br J Psychiatry. 1990, 157: 894-901. 10.1192/bjp.157.6.894.
Article
CAS
PubMed
Google Scholar
Lanctôt KL, Herrmann N, van Reekum R, Eryavec G, Naranjo CA: Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer‘s disease. Int J Geriatr Psychiatry. 2002, 17: 531-541. 10.1002/gps.636.
Article
PubMed
Google Scholar
Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR, Huber KA: A double-blind comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia. Am J Geriatr Psychiatry. 2007, 15: 942-52. 10.1097/JGP.0b013e3180cc1ff5.
Article
PubMed
Google Scholar
Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L: Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Int Psychogeriatr. 2005, 17: 617-29. 10.1017/S1041610205002280.
Article
PubMed
Google Scholar